The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea
The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea (LOFT-HF)
Sponsor: Brigham and Women's Hospital
Terminated
Low feasibility of completion within the study period due to delayed site activation and slow participant accrual
Other terminated trials from Brigham and Women's Hospital
Listed as NCT03745898, this PHASE3 trial focuses on Central Sleep Apnea and Heart Failure and remains terminated or withdrawn. Sponsored by Brigham and Women's Hospital, it has been updated 15 times since 2019, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Sep 2023 — Jul 2024 [monthly]
Terminated PHASE3
-
Sep 2022 — Sep 2023 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
▶ Show 10 earlier versions
-
Jun 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE3
-
Sep 2021 — Jun 2022 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE3
-
Feb 2020 — Jun 2020 [monthly]
Recruiting PHASE3
-
Oct 2019 — Feb 2020 [monthly]
Recruiting PHASE3
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Dec 2018 — Sep 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Ohio State University
For direct contact, visit the study record on ClinicalTrials.gov .